Briacell Therapeutics company

60 Degrees Pharmaceuticals A2Z Cust2Mate Solutions Corp. acquisition applied uv inc. At The Market offering Barry Biggar Blog broker business business combination Calidi Biotherapeutics cannabis law Carmel Milazzo Feil LLP closing bell cmf combination corporate law firm corporate litigation Craft Capital Management LLC D. Boral Capital de-spac Debt direct offering EF Hutton Events finra guide inspire veterinary partners news NYC NYC law firm pa capital markets pa corporate law group pa exchange act reporting compliance matters pa registration statements pa restricted stock beneficial ownership filings pa securities law group pharmaceutical PIPES pr pra capital markets pra corporate law group pra exchange act reporting compliance matters pra mergers acquisitions pra registration statements pra restricted stock beneficial ownership filings pra securities law group press release purchase agreement Qualigen Therapeutics Reg A+ warrant inducement offering Revere Securities Reverse Merger roth capital partners SEC securities securities law firm securities law firm securities lawyers sicheniza ross ference sichenzia ross sichenzia ross ference sichenzia ross ference carmel sichenzia ross ference kesner sichenzia ross friedman ference spac Sponsorshop Sports & Entertainment Law SRFC srff srfk llp srf law transaction transactions-prior 公司法律事務組證券法

Sichenzia Ross Ference Carmel LLP 代表 BriaCell Therapeutics 进行 500 万美元的发行

2 10 月, 2024

新闻稿 – 纽约州纽约 – 2024 年 10 月 1 日 – Sichenzia Ross Ference Carmel LLP 今天宣布，它代表 BriaCell Therapeutics Corp.（纳斯达克股票代码：BCTX、BCTXW）（多伦多证券交易所股票代码：BCT），这是一家开发新型免疫疗法的临床阶段生物技术公司为了改变癌症护理，其尽最大努力发行 5,128,500 …

Continue Reading about Sichenzia Ross Ference Carmel LLP 代表 BriaCell Therapeutics 进行 500 万美元的发行 →

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.